Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling
EndocrinologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Health technology assessment (Winchester, England)
- Publicado em
- 1 dez 2024
- Citações
- 29
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling
Asra Asgharzadeh, Mubarak Patel, Martin Connock, Sarah Damery, Iman Ghosh, Mary Jordan, Karoline Freeman, Anna Brown, Rachel Court, Sharin Baldwin et al.
Descritores MeSH
- Insulin
- Insulin Infusion Systems
- Blood Glucose Self-Monitoring
- Blood Glucose
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 1
- Algorithms
- Quality-Adjusted Life Years
- Glycated Hemoglobin
- Humans
Veja também
Estudos relacionados
- Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents With Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial
- Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?
- Cost-effectiveness of the MiniMed 780G system for type 1 diabetes
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Efeitos Metabólicos e Psicológicos de Mylife CamAPS FX Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes, Markedly Elevated HbA1c, and Psychological Vulnerability: The Hi-Loop Randomized Clinical Trial